Vitamin K and cancer

References

• Kurosu M, Begari E. Vitamin K2 in electron transport system: are enzymes involved in vitamin K2 biosynthesis promising drug targets? Molecules 2010;15:1531–53.
   PubMed Web of Science ®Google Scholar
• Merrifield LS, Yang HY. Vitamin K5 as a fungistatic agent. Appl Microbiol 1965;13:660–2.
   PubMedGoogle Scholar
• Stenflo J, Fernlund P, Egan W, Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A 1974;71:2730–3.
   PubMed Web of Science ®Google Scholar
• Weston BW, Monahan PE. Familial deficiency of vitamin K-dependent clotting factors. Haemophilia 2008;14:1209–13.
   PubMed Web of Science ®Google Scholar
• Willems BA, Vermeer C, Reutelingsperger CP, Schurgers LJ. The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. Mol Nutr Food Res 2014;58:1620–35.
   PubMed Web of Science ®Google Scholar
• Dauti F, Hjaltalin Jonsson M, Hillarp A, Bentzer P, Schott U. Perioperative changes in PIVKA-II. Scand J Clin Lab Invest 2015;75:562–7.
   PubMed Web of Science ®Google Scholar
• Thomas O, Rein H, Strandberg K, Schott U. Coagulative safety of epidural catheters after major upper gastrointestinal surgery: advanced and routine coagulation analysis in 38 patients. Perioper Med (Lond) 2016;5:28.
   PubMedGoogle Scholar
• Dahlberg S, Nilsson CU, Kander T, Schott U. Detection of subclinical vitamin K deficiency in neurosurgery with PIVKA-II. Scand J Clin Lab Invest 2017;77:267–74.
   PubMed Web of Science ®Google Scholar
• Gong X, Gutala R, Jaiswal AK. Quinone oxidoreductases and vitamin K metabolism. Vitam Horm 2008;78:85–101.
   PubMed Web of Science ®Google Scholar
• Criddle DN, Gillies S, Baumgartner-Wilson HK, Jaffar M, Chinje EC, Passmore S, Chvanov M, Barrow S, Gerasimenko OV, Tepikin AV, Sutton R, Petersen OH. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J Biol Chem 2006;281:40485–92.
   PubMed Web of Science ®Google Scholar
• Parker CH, Morgan CR, Rand KD, Engen JR, Jorgenson JW, Stafford DW. A conformational investigation of propeptide binding to the integral membrane protein γ-glutamyl carboxylase using nanodisc hydrogen exchange mass spectrometry. Biochemistry 2014;53:1511–20.
   PubMed Web of Science ®Google Scholar
• Stanley TB, Jin DY, Lin PJ, Stafford DW. The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J Biol Chem 1999;274:16940–4.
   PubMed Web of Science ®Google Scholar
• Kaesler N, Magdeleyns E, Herfs M, Schettgen T, Brandenburg V, Fliser D, Vermeer C, Floege J, Schlieper G, Kruger T. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int 2014;86:286–93.
   PubMed Web of Science ®Google Scholar
• Tie JK, Stafford DW. Structural and functional insights into enzymes of the vitamin K cycle. J Thromb Haemost 2016;14:236–47.
   PubMed Web of Science ®Google Scholar
• Wajih N, Hutson SM, Wallin R. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction. J Biol Chem 2007;282:2626–35.
   PubMed Web of Science ®Google Scholar
• Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, Muller CR, Strom TM, Oldenburg J. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427:537–41.
   PubMed Web of Science ®Google Scholar
• Hammed A, Matagrin B, Spohn G, Prouillac C, Benoit E, Lattard V. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy. J Biol Chem 2013;288:28733–42.
   PubMed Web of Science ®Google Scholar
• Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A 1975;72:3925–9.
   PubMed Web of Science ®Google Scholar
• Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998;23:187–96.
   PubMed Web of Science ®Google Scholar
• Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord 2015;16:93–8.
   PubMed Web of Science ®Google Scholar
• Wei J, Hanna T, Suda N, Karsenty G, Ducy P. Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a . Diabetes 2014;63:1021–31.
   PubMed Web of Science ®Google Scholar
• Korostishevsky M, Malkin I, Trofimov S, Pei Y, Deng HW, Livshits G. Significant association between body composition phenotypes and the osteocalcin genomic region in normative human population. Bone 2012;51:688–94.
   PubMed Web of Science ®Google Scholar
• Liu DM, Guo XZ, Tong HJ, Tao B, Sun LH, Zhao HY, Ning G, Liu JM. Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporos Int 2015;26:2823–33.
   PubMed Web of Science ®Google Scholar
• Liatis S, Sfikakis PP, Tsiakou A, Stathi C, Terpos E, Katsilambros N, Makrilakis K. Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals. Diabetes Metab 2014;40:198–203.
   PubMed Web of Science ®Google Scholar
• Mori K, Emoto M, Motoyama K, Lee E, Yamada S, Morioka T, Imanishi Y, Shoji T, Inaba M. Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2012;4:53.
   PubMed Web of Science ®Google Scholar
• Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983;117:765–71.
   PubMed Web of Science ®Google Scholar
• Wang C, Jin H, Wang N, Fan S, Wang Y, Zhang Y, Wei L, Tao X, Gu D, Zhao F, Fang J, Yao M, Qin W. Gas6/Axl axis contributes to chemoresistance and metastasis in breast cancer through Akt/GSK-3β/β-catenin signaling. Theranostics 2016;6:1205–19.
   PubMed Web of Science ®Google Scholar
• Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE, Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA. Warfarin blocks Gas6-mediated Axl activation required for pancreatic cancer epithelial plasticity and metastasis. Cancer Res 2015;75:3699–705.
   PubMed Web of Science ®Google Scholar
• Viegas CS, Simes DC, Laize V, Williamson MK, Price PA, Cancela ML. Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 2008;283:36655–64.
   PubMed Web of Science ®Google Scholar
• Viegas CS, Cavaco S, Neves PL, Ferreira A, Joao A, Williamson MK, Price PA, Cancela ML, Simes DC. Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. Am J Pathol 2009;175:2288–98.
   PubMed Web of Science ®Google Scholar
• Kulman JD, Harris JE, Xie L, Davie EW. Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. Proc Natl Acad Sci USA 2001;98:1370–5.
   PubMed Web of Science ®Google Scholar
• Kulman JD, Harris JE, Xie L, Davie EW. Proline-rich Gla protein 2 is a cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator Yes-associated protein. Proc Natl Acad Sci USA 2007;104:8767–72.
   PubMed Web of Science ®Google Scholar
• Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 2008;283:17991–8001.
   PubMed Web of Science ®Google Scholar
• Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, Kruzynska-Frejtag A, Feng JQ, Conway SJ. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 2005;25:11131–44.
   PubMed Web of Science ®Google Scholar
• Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002;62:5358–64.
   PubMed Web of Science ®Google Scholar
• Kuhn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, Keating MT. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007;13:962–9.
   PubMed Web of Science ®Google Scholar
• Xu CH, Wang W, Lin Y, Qian LH, Zhang XW, Wang QB, Yu LK. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer. Oncotarget 2017;8:18746–53.
   PubMed Web of Science ®Google Scholar
• Jang SY, Park SY, Lee HW, Choi YK, Park KG, Yoon GS, Tak WY, Kweon YO, Hur K, Lee WK. The combination of periostin overexpression and microvascular invasion is related to a poor prognosis for hepatocellular carcinoma. Gut Liver 2016;10:948–54.
   PubMed Web of Science ®Google Scholar
• Guo YS, Zhao R, Ma J, Cui W, Sun Z, Gao B, He S, Han YH, Fan J, Yang L, Tang J, Luo ZJ. betaig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin alpha2beta1 and activating PI3K signaling pathway. PLoS One 2014;9:e90220.
   PubMed Web of Science ®Google Scholar
• Annis DS, Ma H, Balas DM, Kumfer KT, Sandbo N, Potts GK, Coon JJ, Mosher DF. Absence of vitamin K-dependent γ-carboxylation in human periostin extracted from fibrotic lung or secreted from a cell line engineered to optimize γ-carboxylation. PLoS One 2015;10:e0135374.
   PubMed Web of Science ®Google Scholar
• Shea MK, Booth SL, Massaro JM, Jacques PF, D'agostino RB Sr, Dawson-Hughes B, Ordovas JM, O'donnell CJ, Kathiresan S, Keaney JF Jr, Vasan RS, Benjamin EJ. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008;167:313–20.
   PubMed Web of Science ®Google Scholar
• Ohsaki Y, Shirakawa H, Hiwatashi K, Furukawa Y, Mizutani T, Komai M. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006;70:926–32.
   PubMed Web of Science ®Google Scholar
• Pan MH, Maresz K, Lee PS, Wu JC, Ho CT, Popko J, Mehta DS, Stohs SJ, Badmaev V. Inhibition of TNF-alpha, IL-1alpha, and IL-1beta by pretreatment of human monocyte-derived macrophages with menaquinone-7 and cell activation with TLR agonists in vitro. J Med Food 2016;19:663–9.
   PubMed Web of Science ®Google Scholar
• Fujii S, Shimizu A, Takeda N, Oguchi K, Katsurai T, Shirakawa H, Komai M, Kagechika H. Systematic synthesis and anti-inflammatory activity of omega-carboxylated menaquinone derivatives – investigations on identified and putative vitamin K(2) metabolites. Bioorg Med Chem 2015;23:2344–52.
   PubMed Web of Science ®Google Scholar
• Tjwa M, Bellido-Martin L, Lin Y, Lutgens E, Plaisance S, Bono F, Delesque-Touchard N, Herve C, Moura R, Billiau AD, Aparicio C, Levi M, Daemen M, Dewerchin M, Lupu F, Arnout J, Herbert JM, Waer M, Garcia de Frutos P, Dahlback B, Carmeliet P, Hoylaerts MF, Moons L. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 2008;111:4096–105.
   PubMed Web of Science ®Google Scholar
• Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 2008;100:604–10.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–74.
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013;13:759–71.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009;125:1747–54.
   PubMed Web of Science ®Google Scholar
• Tantisattamo E, Han KH, O'neill WC. Increased vascular calcification in patients receiving warfarin. Arterioscler Thromb Vasc Biol 2015;35:237–42.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Joosen IA, Laufer EM, Chatrou ML, Herfs M, Winkens MH, Westenfeld R, Veulemans V, Krueger T, Shanahan CM, Jahnen-Dechent W, Biessen E, Narula J, Vermeer C, Hofstra L, Reutelingsperger CP. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One 2012;7:e43229.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007;5:2503–11.
   PubMed Web of Science ®Google Scholar
• Shea MK, O'donnell CJ, Vermeer C, Magdeleyns EJ, Crosier MD, Gundberg CM, Ordovas JM, Kritchevsky SB, Booth SL. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 2011;141:1529–34.
   PubMed Web of Science ®Google Scholar
• Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, Beulens JW. Circulating desphospho-uncarboxylated matrix gamma-carboxyglutamate protein and the risk of coronary heart disease and stroke. J Thromb Haemost 2014;12:1028–34.
   PubMed Web of Science ®Google Scholar
• Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998;18:1400–7.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007;109:2823–31.
   PubMed Web of Science ®Google Scholar
• Namba S, Yamaoka-Tojo M, Hashikata T, Ikeda Y, Kitasato L, Hashimoto T, Shimohama T, Tojo T, Takahira N, Masuda T, Ako J. Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis. BBA Clin 2015;4:76–80.
   PubMed Web of Science ®Google Scholar
• Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damiao R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gomez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet 2012;379:39–46.
   PubMed Web of Science ®Google Scholar
• Nakano T, Kawamoto K, Kishino J, Nomura K, Higashino K, Arita H. Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem J 1997;323:387–92.
   PubMed Web of Science ®Google Scholar
• Son BK, Kozaki K, Iijima K, Eto M, Kojima T, Ota H, Senda Y, Maemura K, Nakano T, Akishita M, Ouchi Y. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 2006;98:1024–31.
   PubMed Web of Science ®Google Scholar
• Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell CJ Jr, Forcier RJ, Edwards RL, Headley E, Kim SH, O'donnell JF. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 1984;53:2046–52.
   PubMed Web of Science ®Google Scholar
• Smorenburg SM, Vink R, Otten HM, Swaneveld F, Buller HR. The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis. Thromb Haemost 2001;86:1586–7.
   PubMed Web of Science ®Google Scholar
• Pengo V, Noventa F, Denas G, Pengo MF, Gallo U, Grion AM, Iliceto S, Prandoni P. Long-term use of vitamin K antagonists and incidence of cancer: a population-based study. Blood 2011;117:1707–9.
   PubMed Web of Science ®Google Scholar
• Tagalakis V, Tamim H, Blostein M, Collet JP, Hanley JA, Kahn SR. Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study. Lancet Oncol 2007;8:395–402.
   PubMed Web of Science ®Google Scholar
• Tew BY, Pal SK, He M, Tong T, Wu H, Hsu J, Liu X, Neuhausen SL, Jones JO. Vitamin K epoxide reductase expression and prostate cancer risk. Urol Oncol 2017;35:112.e13–e18.
   PubMed Web of Science ®Google Scholar
• Tew BY, Hong TB, Otto-Duessel M, Elix C, Castro E, He M, Wu X, Pal SK, Kalkum M, Jones JO. Vitamin K epoxide reductase regulation of androgen receptor activity. Oncotarget 2017;8:13818–31.
   PubMed Web of Science ®Google Scholar
• Ji J, Zoller B, Giaccia A, Haile R, Sundquist J, Sundquist K. Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden. Breast Cancer Res Treat 2015;154:369–75.
   PubMed Web of Science ®Google Scholar
• Ahern TP, Pedersen L, Svaerke C, Rothman KJ, Sorensen HT, Lash TL. The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable. Am J Epidemiol 2011;174:1382–90.
   PubMed Web of Science ®Google Scholar
• Pottegard A, Friis S, Hallas J. Cancer risk in long-term users of vitamin K antagonists: a population-based case-control study. Int J Cancer 2013;132:2606–12.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Hitomi M, Yoshiji H, Nonomura T, Tsujimoto T, Mitoro A, Akahane T, Ogawa M, Nakai S, Deguchi A, Masaki T, Uchida N. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int J Oncol 2005;27:505–11.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, Yoshiji H, Kuriyama S. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol 2007;31:323–31.
   PubMed Web of Science ®Google Scholar
• Linsalata M, Orlando A, Tutino V, Notarnicola M, D'attoma B, Russo F. Inhibitory effect of vitamin K1 on growth and polyamine biosynthesis of human gastric and colon carcinoma cell lines. Int J Oncol 2015;47:773–81.
   PubMed Web of Science ®Google Scholar
• Kitagawa J, Hara T, Tsurumi H, Ninomiya S, Ogawa K, Adachi S, Kanemura N, Kasahara S, Shimizu M, Moriwaki H. Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2. J Cancer Res Clin Oncol 2011;137:779–87.
   PubMed Web of Science ®Google Scholar
• Shah M, Stebbins JL, Dewing A, Qi J, Pellecchia M, Ronai ZA. Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res 2009;22:799–808.
   PubMed Web of Science ®Google Scholar
• Maniwa Y, Kasukabe T, Kumakura S. Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells. Int J Oncol 2015;47:473–80.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang Z, Wang B, Wang Y, Hu X. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2. Cancer Lett 2012;316:204–10.
   PubMed Web of Science ®Google Scholar
• Luo W, Hu H, Chang R, Zhong J, Knabel M, O'meally R, Cole RN, Pandey A, Semenza GL. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011;145:732–44.
   PubMed Web of Science ®Google Scholar
• Kitano T, Yoda H, Tabata K, Miura M, Toriyama M, Motohashi S, Suzuki T. Vitamin K3 analogs induce selective tumor cytotoxicity in neuroblastoma. Biol Pharm Bull 2012;35:617–23.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kumar M, Garg S, Hissar S, Pandey C, Sharma BC. High dose vitamin K3 infusion in advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2006;21:1478–82.
   PubMed Web of Science ®Google Scholar
• He T, Hatem E, Vernis L, Lei M, Huang ME. PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug. J Exp Clin Cancer Res 2015;34:152.
   PubMed Web of Science ®Google Scholar
• Vita MF, Nagachar N, Avramidis D, Delwar ZM, Cruz MH, Siden A, Paulsson KM, Yakisich JS. Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C. Invest New Drugs 2011;29:1314–20.
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Jamison JM, Summers JL. Pro-oxidant treatment of human prostate carcinoma (DU145) induces autoschizis cell death: autophagosomes build up out of injured endomembranes and mitochondria. Ultrastruct Pathol 2014;38:315–28.
   PubMed Web of Science ®Google Scholar
• Gilloteaux J, Jamison JM, Lorimer HE, Jarjoura D, Taper HS, Calderon PB, Neal DR, Summers JL. Autoschizis: a new form of cell death for human ovarian carcinoma cells following ascorbate:menadione treatment. Nuclear and DNA degradation. Tissue Cell 2004;36:197–209.
   PubMed Web of Science ®Google Scholar
• Taper HS. Altered deoxyribonuclease activity in cancer cells and its role in non toxic adjuvant cancer therapy with mixed vitamins C and K3. Anticancer Res 2008;28:2727–32.
   PubMed Web of Science ®Google Scholar
• Tareen B, Summers JL, Jamison JM, Neal DR, McGuire K, Gerson L, Diokno A. A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci 2008;5:62–7.
   PubMedGoogle Scholar
• Oh SJ, Han HK, Kang KW, Lee YJ, Lee MY. Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity. Arch Pharm Res 2013;36:509–16.
   PubMed Web of Science ®Google Scholar
• Azuma K, Urano T, Ouchi Y, Inoue S. Vitamin K2 suppresses proliferation and motility of hepatocellular carcinoma cells by activating steroid and xenobiotic receptor. Endocr J 2009;56:843–9.
   PubMed Web of Science ®Google Scholar
• Knapen MH, Braam LA, Teunissen KJ, Zwijsen RM, Theuwissen E, Vermeer C. Yogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population. J Nutr Sci 2015;4:e35.
   PubMed Web of Science ®Google Scholar
• Homma K, Wakana N, Suzuki Y, Nukui M, Daimatsu T, Tanaka E, Tanaka K, Koga Y, Nakajima Y, Nakazawa H. Treatment of natto, a fermented soybean preparation, to prevent excessive plasma vitamin K concentrations in patients taking warfarin. J Nutr Sci Vitaminol (Tokyo) 2006;52:297–301.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Teunissen KJ, Hamulyak K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007;109:3279–83.
   PubMed Web of Science ®Google Scholar
• Kiely M, Hodgins SJ, Merrigan BA, Tormey S, Kiely PA, O'connor EM. Real-time cell analysis of the inhibitory effect of vitamin K2 on adhesion and proliferation of breast cancer cells. Nutr Res 2015;35:736–43.
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Yang W, Bosland MC. Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol 2014;140:116–32.
   PubMed Web of Science ®Google Scholar
• Nishio K, Niwa Y, Toyoshima H, Tamakoshi K, Kondo T, Yatsuya H, Yamamoto A, Suzuki S, Tokudome S, Lin Y, Wakai K, Hamajima N, Tamakoshi A. Consumption of soy foods and the risk of breast cancer: findings from the Japan Collaborative Cohort (JACC) Study. Cancer Causes Control 2007;18:801–8.
   PubMed Web of Science ®Google Scholar
• Messina M. Impact of soy foods on the development of breast cancer and the prognosis of breast cancer patients. Forsch Komplementmed 2016;23:75–80.
   PubMedGoogle Scholar
• Wada K, Tsuji M, Tamura T, Konishi K, Kawachi T, Hori A, Tanabashi S, Matsushita S, Tokimitsu N, Nagata C. Soy isoflavone intake and stomach cancer risk in Japan: from the Takayama study. Int J Cancer 2015;137:885–92.
   PubMed Web of Science ®Google Scholar
• Kweon SS, Shu XO, Xiang Y, Cai H, Yang G, Ji BT, Li H, Gao YT, Zheng W, Epplein M. Intake of specific nonfermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population. J Nutr 2013;143:1736–42.
   PubMed Web of Science ®Google Scholar
• Yue P, Gao ZH, Xue X, Cui SX, Zhao CR, Yuan Y, Yin Z, Inagaki Y, Kokudo N, Tang W, Qu XJ. Des-gamma-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway. Eur J Cancer 2011;47:1115–24.
   PubMed Web of Science ®Google Scholar
• Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 2002;97:425–31.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, Koike K, Takaki A, Shiratori Y. Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005;280:6409–15.
   PubMed Web of Science ®Google Scholar
• Chu KJ, Lai EC, Yao XP, Zhang HW, Lau WY, Fu XH, Lu CD, Shi J, Cheng SQ. Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation – a systematic review and meta-analysis. Asian J Surg 2010;33:120–6.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Shiratori Y, Kudo M, Shiina S, Mizuta T, Kojiro M, Yamamoto K, Koike Y, Saito K, Koyanagi N, Kawabe T, Kawazoe S, Kobashi H, Kasugai H, Osaki Y, Araki Y, Izumi N, Oka H, Tsuji K, Toyota J, Seki T, Osawa T, Masaki N, Ichinose M, Seike M, Ishikawa A, Ueno Y, Tagawa K, Kuromatsu R, Sakisaka S, Ikeda H, Kuroda H, Kokuryu H, Yamashita T, Sakaida I, Katamoto T, Kikuchi K, Nomoto M, Omata M. Effect of vitamin K2 on the recurrence of hepatocellular carcinoma. Hepatology 2011;54:532–40.
   PubMed Web of Science ®Google Scholar
• Riaz IB, Riaz H, Riaz T, Rahman S, Amir M, Badshah MB, Kazi AN. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2012;12:170.
   PubMed Web of Science ®Google Scholar
• Jung DH, Hwang S, Song GW, Ryoo BY, Kim N, Tak E, Hong HN. An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib. Korean J Hepatobiliary Pancreat Surg 2015;19:1–5.
   PubMedGoogle Scholar
• Hasanbasic I, Rajotte I, Blostein M. The role of gamma-carboxylation in the anti-apoptotic function of gas6. J Thromb Haemost 2005;3:2790–7.
   PubMed Web of Science ®Google Scholar
• Sawabu T, Seno H, Kawashima T, Fukuda A, Uenoyama Y, Kawada M, Kanda N, Sekikawa A, Fukui H, Yanagita M, Yoshibayashi H, Satoh S, Sakai Y, Nakano T, Chiba T. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 2007;46:155–64.
   PubMed Web of Science ®Google Scholar
• Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlback B, Carmeliet P. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215–21.
   PubMed Web of Science ®Google Scholar
• Eichinger S. Cancer associated thrombosis: risk factors and outcomes. Thromb Res 2016;140:S12–S7.
   PubMed Web of Science ®Google Scholar
• Aghourian MN, Lemarie CA, Bertin FR, Blostein MD. Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis. Blood 2016;127:769–77.
   PubMed Web of Science ®Google Scholar
• Gheorghe SR, Craciun AM. Matrix Gla protein in tumoral pathology. Clujul Med 2016;89:319–21.
   PubMedGoogle Scholar
• Fan C, Sheu D, Fan H, Hsu K, Allen Chang C, Chan E. Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas. Cancer Lett 2001;165:63–9.
   PubMed Web of Science ®Google Scholar
• Tiago DM, Conceicao N, Caiado H, Laize V, Cancela ML. Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells. FEBS Lett 2016;590:1234–41.
   PubMed Web of Science ®Google Scholar
• Mertsch S, Schurgers LJ, Weber K, Paulus W, Senner V. Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma. BMC Cancer 2009;9:302.
   PubMed Web of Science ®Google Scholar
• Nishimoto SK, Nishimoto M. Matrix gla protein binds to fibronectin and enhances cell attachment and spreading on fibronectin. Int J Cell Biol 2014;2014:807013.
   PubMedGoogle Scholar
• Bostrom K, Zebboudj AF, Yao Y, Lin TS, Torres A. Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells. J Biol Chem 2004;279:52904–13.
   PubMed Web of Science ®Google Scholar
• Kuzontkoski PM, Mulligan-Kehoe MJ, Harris BT, Israel MA. Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels. Oncogene 2010;29:3793–802.
   PubMed Web of Science ®Google Scholar
• Sharma T, Radosevich JA, Pachori G, Mandal CC. A molecular view of pathological microcalcification in breast cancer. J Mammary Gland Biol Neoplasia 2016;21:25–40.
   PubMed Web of Science ®Google Scholar
• Viegas CS, Herfs M, Rafael MS, Enriquez JL, Teixeira A, Luis IM, van 'T Hoofd CM, Joao A, Maria VL, Cavaco S, Ferreira A, Serra M, Theuwissen E, Vermeer C, Simes DC. Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP–mineral interaction. Biomed Res Int 2014;2014:340216.
   PubMed Web of Science ®Google Scholar
• Theuwissen E, Magdeleyns EJ, Braam LA, Teunissen KJ, Knapen MH, Binnekamp IA, van Summeren MJ, Vermeer C. Vitamin K status in healthy volunteers. Food Funct 2014;5:229–34.
   PubMed Web of Science ®Google Scholar
• Zafeirakis AG, Papatheodorou GA, Limouris GS. Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases. Nucl Med Commun 2010;31:249–53.
   PubMed Web of Science ®Google Scholar
• Shih WJ, Wierzbinski B, Collins J, Magoun S, Chen IW, Ryo UY. Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements. J Nucl Med 1990;31:1486–9.
   PubMed Web of Science ®Google Scholar
• Bayrak SB, Ceylan E, Serter M, Karadag F, Demir E, Cildag O. The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer. Int J Clin Oncol 2012;17:112–18.
   PubMed Web of Science ®Google Scholar
• Alatas F, Alatas O, Metintas M, Colak O, Erginel S, Harmanci E. Usefulness of bone markers for detection of bone metastases in lung cancer patients. Clin Biochem 2002;35:293–6.
   PubMed Web of Science ®Google Scholar
• Gao Y, Lu H, Luo Q, Wu X, Sheng S. Predictive value of osteocalcin in bone metastatic differentiated thyroid carcinoma. Clin Biochem 2010;43:291–5.
   PubMed Web of Science ®Google Scholar
• David Roodman G, Silbermann R. Mechanisms of osteolytic and osteoblastic skeletal lesions. Bonekey Rep 2015;4:753.
   PubMed Web of Science ®Google Scholar
• Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134:3100–5.
   PubMed Web of Science ®Google Scholar
• Nimptsch K, Rohrmann S, Kaaks R, Linseisen J. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr 2010;91:1348–58.
   PubMed Web of Science ®Google Scholar
• Juanola-Falgarona M, Salas-Salvado J, Martinez-Gonzalez MA, Corella D, Estruch R, Ros E, Fito M, Aros F, Gomez-Gracia E, Fiol M, Lapetra J, Basora J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Munoz MA, Ruiz-Gutierrez V, Fernandez-Ballart J, Bullo M. Dietary intake of vitamin K is inversely associated with mortality risk. J Nutr 2014;144:743–50.
   PubMed Web of Science ®Google Scholar
• Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191–308.
   PubMed Web of Science ®Google Scholar
• Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Scarmo S, Schairer C, Schouten LJ, Shikany JM, Sieri S, Tsugane S, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Zhang X, Ziegler RG, Smith-Warner SA. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 2013;105:219–36.
   PubMedGoogle Scholar
• Han B, Li X, Yu T. Cruciferous vegetables consumption and the risk of ovarian cancer: a meta-analysis of observational studies. Diagn Pathol 2014;9:7.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011;105:S77–S81.
   PubMed Web of Science ®Google Scholar
• Wicki A, Hagmann J. Diet and cancer. Swiss Med Wkly 2011;141:w13250.
   PubMed Web of Science ®Google Scholar
• Bradbury KE, Appleby PN, Key TJ. Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 2014;100:394s–8s.
   PubMed Web of Science ®Google Scholar
• Basen-Engquist K, Chang M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 2011;13:71–6.
   PubMed Web of Science ®Google Scholar
• Shea MK, Booth SL. Concepts and controversies in evaluating vitamin K status in population-based studies. Nutrients 2016;8. doi:10.3390/nu8010008
   PubMed Web of Science ®Google Scholar
• Truong JT, Fu X, Saltzman E, Al Rajabi A, Dallal GE, Gundberg CM, Booth SL. Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J Nutr 2012;142:936–41.
   PubMed Web of Science ®Google Scholar
• Ferland G, Sadowski JA, O'brien ME. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993;91:1761–8.
   PubMed Web of Science ®Google Scholar